Xbrane Biopharma Investor Relations Material
Latest events
Q2 2025
Xbrane Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xbrane Biopharma
Access all reports
Xbrane Biopharma is a biotechnology company that develops, manufactures and sells biosimilars worldwide. Many of the company's products are approved to treat cancer patients. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.
Key slides for Xbrane Biopharma
Q2 2025
Xbrane Biopharma
Q2 2025
Xbrane Biopharma
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
XBRANE
Country
🇸🇪 Sweden